AU2654792A - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
AU2654792A
AU2654792A AU26547/92A AU2654792A AU2654792A AU 2654792 A AU2654792 A AU 2654792A AU 26547/92 A AU26547/92 A AU 26547/92A AU 2654792 A AU2654792 A AU 2654792A AU 2654792 A AU2654792 A AU 2654792A
Authority
AU
Australia
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26547/92A
Other languages
English (en)
Inventor
Robert Michael Demarinis
Francis Richard Pfeiffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2654792A publication Critical patent/AU2654792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU26547/92A 1991-09-12 1992-09-11 Chemical compounds Abandoned AU2654792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919119467A GB9119467D0 (en) 1991-09-12 1991-09-12 Chemical compounds
GB9119467 1991-09-12

Publications (1)

Publication Number Publication Date
AU2654792A true AU2654792A (en) 1993-04-05

Family

ID=10701273

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26547/92A Abandoned AU2654792A (en) 1991-09-12 1992-09-11 Chemical compounds

Country Status (5)

Country Link
EP (1) EP0603314A4 (fr)
JP (1) JPH06510545A (fr)
AU (1) AU2654792A (fr)
GB (1) GB9119467D0 (fr)
WO (1) WO1993004686A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007353A1 (fr) * 1997-08-05 1999-02-18 The Mount Sinai School Of Medicine Of The City University Of New York UTILISATION D'ANTAGONISTES DE RECEPTEUR α1A-ADRENERGIQUE DANS LA THERAPIE DU GLAUCOME
BR9916162A (pt) * 1998-12-14 2001-09-04 Cellegy Pharma Inc Composição e método para o tratamento de um distúrbio anorretal e para controlar a dor associada com o mesmo
WO2003042190A1 (fr) 2001-11-12 2003-05-22 Pfizer Products Inc. Derives de n-adamantylalkyle benzamide en tant qu'antagonistes du recepteur p2x7
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
KR100897642B1 (ko) 2002-12-20 2009-05-14 글락소 그룹 리미티드 신경 장애 치료용 벤즈아제핀 유도체
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
ATE355273T1 (de) 2003-05-12 2006-03-15 Pfizer Prod Inc Benzamidinhibitoren des p2x7-rezeptors
AU2004283452A1 (en) * 2003-10-23 2005-05-06 F. Hoffmann-La Roche Ag Benzazepine derivatives as MAO-B inhibitors
SI1720836T1 (sl) 2004-02-25 2014-06-30 Eli Lilly And Company 6-substituirani 2,3,4,5-tetrahidro-1h-benzo (d)azepini kot agonisti 5-ht2c receptorja
WO2006003500A1 (fr) 2004-06-29 2006-01-12 Pfizer Products Inc. Procedes permettant de preparer des derives de 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h-[1,2,4]triazin-2-yl]-benzamides par deprotection des precurseurs proteges par hydroxyle
CA2619450C (fr) * 2005-09-01 2013-10-22 Eli Lilly And Company 2,3,4,5-tetrahydro-1h-benzo[d]azepines substituees par un heterocycle a liaison 6-n en tant qu'agonistes de recepteur 5-ht2c
ATE438627T1 (de) 2005-09-01 2009-08-15 Lilly Co Eli 6-substituierte- 2,3,4,5-tetrahydro-1h- benzoädüazepine als 5-ht2c-rezeptoragonisten
CN101253153A (zh) 2005-09-01 2008-08-27 伊莱利利公司 作为5－HT<sub>2c</sub>受体激动剂的6－取代的2,3,4,5－四氢－1H－苯并[d]氮杂䓬
AU2006287202B2 (en) 2005-09-01 2013-01-24 Eli Lilly And Company 6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
EP0285287A3 (fr) * 1987-03-23 1990-08-16 Smithkline Beecham Corporation Emploi de 3-benzazépines pour le traitement des troubles de la mobilité gastro-intestinale

Also Published As

Publication number Publication date
GB9119467D0 (en) 1991-10-23
JPH06510545A (ja) 1994-11-24
EP0603314A1 (fr) 1994-06-29
WO1993004686A1 (fr) 1993-03-18
EP0603314A4 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
AU1704492A (en) Chemical compounds
AU1168495A (en) Chemical compounds
GB9103862D0 (en) Chemical compounds
GB9105152D0 (en) Chemical compounds
AU2654792A (en) Chemical compounds
GB9103770D0 (en) Chemical compounds
AU2156192A (en) Chemical compounds
AU1975092A (en) Compounds
GB9100431D0 (en) Chemical compounds
AU4604193A (en) Chemical compound
AU5922994A (en) Oxazinobenzazole compounds
AU2072092A (en) A87689 compounds
GB9100637D0 (en) Chemical compounds
GB9106350D0 (en) Chemical compounds
GB9100430D0 (en) Chemical compounds
GB9100442D0 (en) Chemical compounds
GB9100426D0 (en) Chemical compounds
GB9100427D0 (en) Chemical compounds
GB9100428D0 (en) Chemical compounds
GB9100429D0 (en) Chemical compounds
GB9100424D0 (en) Chemical compounds
GB9100423D0 (en) Chemical compounds
GB9100432D0 (en) Chemical compounds
GB9100433D0 (en) Chemical compounds
GB9100434D0 (en) Chemical compounds